Patent classifications
C08F216/12
AMORPHOUS FLUORINATED COPOLYMERS AND METHODS OF MAKING AND USING THE SAME
Described herein are amorphous fluorinated copolymers produced by the polymerization of one or more fluorinated ring monomers and one or more fluorinated comonomers containing multiple ether oxygens. The copolymers are suitable in many high-technology applications, such as optical fibers, anti-reflection coatings, protective coatings, and gas separation membranes. In one aspect, the copolymers are useful is in the field of membrane-based gas separation processes. In one aspect, amorphous copolymer is produced by polymerizing (a) one or more fluorinated ring monomers in the amount of 1 mol % to 99.5 mol %, wherein the fluorinated ring monomer is at least a five membered ring and (b) a comonomer in the amount of from 0.5 mol % to 99 mol %, wherein the comonomer comprises a fluorinated compound with two or more ether oxygens.
Additively manufactured thermoset polymers for metal plating and metal plated parts formed therefrom
A thermoset resin for forming parts to be metal plated includes a vat photopolymerization (VPP) thermoset resin and an etchable phase disposed in the VPP thermoset resin. The etchable phase is etched from a surface of a part formed from the VPP thermoset resin such that a plurality of micro-mechanical locking sites is formed on the surface of the part. The etchable phase is at least one of organic particles, organic resins, inorganic particles, and copolymers of the VPP thermoset resin. For example, the etchable phase can be a polybutadiene phase and/or a mineral such as calcium carbonate.
COPOLYMER AND COMPOSITE MATERIAL
A copolymer is formed by reacting (A) aromatic monomer, an oligomer thereof, or a polymer thereof, with (B) aliphatic monomer, an oligomer thereof, or a polymer thereof. The aromatic monomer has a chemical structure of
##STR00001##
in which each of R.sup.1 is independently H or CH.sub.3, and n=1-4. R.sup.2 is a single bond, —O—,
##STR00002##
Each of R.sup.3 is independently
##STR00003##
Aqueous dispersion of multistage polymer
An aqueous dispersion of a hydrophobically-modified alkali-soluble multistage polymer useful as a thickener affording high thickening efficiency and an aqueous coating composition comprising such aqueous dispersion showing good stability after heat aging without compromising stability upon addition of colorants.
(PER)FLUOROPOLYETHER POLYMER COMPOSITIONS
The present invention relates to compositions comprising at least one (per)fluoropolyether base oil and at least one polymer obtained by the copolymerization of (per)fluoropolyether (PFPE), tetrafluoroethylene (TFE) and at least one non-homopolymerizable olefin.
(PER)FLUOROPOLYETHER POLYMER COMPOSITIONS
The present invention relates to compositions comprising at least one (per)fluoropolyether base oil and at least one polymer obtained by the copolymerization of (per)fluoropolyether (PFPE), tetrafluoroethylene (TFE) and at least one non-homopolymerizable olefin.
BINDERS COMPRISING A MONOMER AND AN INITIATOR FOR USE IN ADDITIVE MANUFACTURING
A binder comprises a monomer and an initiator. The monomer comprises at least one of a difunctional monomer and a monofunctional monomer. A method of manufacturing a part includes depositing a layer of particulate material on a working surface; selectively applying a binder in at least one of an edge of the layer of particulate material and an infill pattern representative of a stress of the object; repeating the steps of depositing and selectively applying to form a plurality of layers of particulate material with the applied binder; and exposing the plurality of layers of particulate material with the applied binder to an excitation source to decompose the initiator and initiate polymerization of the monomer to thereby form the green body part.
CURABLE COMPOSITION, CURED ARTICLE USING SAME, AND METHOD FOR PRODUCING CURED ARTICLE
A curable composition includes, per 100 parts by mass of a curable compound, 0.1 to 10.0 parts by mass of a compound (A) including a structure represented by the following general formula (I), and 0.01 to 10.0 parts by mass of a base (B):
##STR00001##
where X represents a chalcogen atom, R.sup.1 and R.sup.2 each independently represent an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, an aryl group, or an aralkyl group, and R.sup.3 and R.sup.4 each independently represent a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, an aryl group, or an aralkyl group.
ULTRAVIOLET CURABLE LIQUID COMPOSITION, ULTRAVIOLET CURING INKJET INK, ULTRAVIOLET CURING WET ELECTROPHOTOGRAPHIC LIQUID DEVELOPER, ULTRAVIOLET CURING ELECTROSTATIC INKJET INK, AND IMAGE FORMING METHOD USING THEREOF
An object of the present invention is to provide an ultraviolet curing liquid composition having high sensitivity, excellent storage stability, low viscosity, and excellent fixability after ultraviolet curing. The ultraviolet curable liquid composition of the present invention is an ultraviolet curable liquid composition containing a cationically polymerizable liquid monomer, a photopolymerization initiator and a photopolymerization sensitizer, wherein the cationically polymerizable liquid monomer is a vinyl ether compound, the photopolymerization initiator includes a compound represented by general formula (1), and the photopolymerization sensitizer includes (A) at least one compound selected from the group consisting of a compound represented by general formula (2) and a compound represented by general formula (3), and (B) at least one compound selected from the group consisting of a compound represented by general formula (4) and a compound represented by general formula (5).
NANOPARTICLES FOR ENCAPSULATING COMPOUNDS, THE PREPARATION AND USES THEREOF
The present invention relates to nanoparticles for encapsulating biologically active compounds, comprising a matrix of new polymer conjugates. The invention also relates to a process for producing both the conjugates and nanoparticles, to compositions containing said conjugates or nanoparticles, and applications thereof. The invention is applicable in the pharmaceutical sector and in the nanotechnology sector.